Iressa User Fee Date Pushed To May; Will Advisory Cmte. Take Second Look?

FDA will take regulatory action on AstraZeneca's Iressa (gefitinib) by May 5

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet